Hartil 5mg 28 tablets — Made in Hungary — Free Delivery

Brand: EGIS
Product Code: Hartil 5mg
Availability: In Stock

$21.88

Add to Cart

Description

Indications

Treatment of arterial hypertension.

Prevention of cardiovascular disease: reduction of cardiovascular morbidity and mortality in patients with:

severe cardiovascular disease of atherothrombotic origin (history of coronary heart disease or stroke or peripheral vascular disease)
diabetes, have at least one cardiovascular risk factor (see section "Pharmacological properties").

Treatment of kidney disease

initial glomerular diabetic nephropathy, as evidenced by the presence of microalbuminuria;
severe glomerular diabetic nephropathy, as evidenced by the presence of macroproteinuria, in patients with at least one cardiovascular risk factor (see section "Pharmacological properties");
severe glomerular non-diabetic nephropathy, as evidenced by the presence of macroproteinuria
≥ 3 g / day (see section "Pharmacological properties").
Treatment of heart failure, accompanied by clinical manifestations.

Secondary prevention after acute myocardial infarction: reduction of mortality in the acute stage of myocardial infarction in patients with clinical signs of heart failure when starting treatment more than 48 hours after the onset of acute myocardial infarction.

Contraindications.

Hypersensitivity to the active substance or to any of the excipients that make up the preparation, or to other ACE inhibitors (see Section "Composition").

A history of angioedema (hereditary, idiopathic, or previously transferred to the background of the use of ACE inhibitors or angiotensin II receptor antagonists).

Simultaneous use with sacubitril / valsartan (see sections "Peculiarities of use" and "Interaction with other medicinal products and other forms of interaction")

Significant bilateral renal artery stenosis or unilateral renal artery stenosis in the presence of a single kidney.

Pregnant women or women planning to become pregnant (see section "Use during pregnancy or lactation").

Ramipril should not be used in patients with arterial hypotension or hemodynamically unstable conditions.

Simultaneous use with preparations containing aliskiren in patients with diabetes or patients with moderate or severe renal impairment (glomerular filtration rate (GFR)

<60 ml / min / 1.73 m2) (see Sections "Interaction with other medicinal products and other forms of interaction" and "Pharmacological").

The simultaneous use of ACE inhibitors and extracorporeal therapies that lead to blood contact with negatively charged surfaces should be avoided, since such use can lead to severe anaphylactic reactions. Such extracorporeal therapies include dialysis or hemofiltration using certain high fluid permeability membranes (eg polyacrylonitrile) and low density lipoprotein apheresis using dextran sulfate.

Compound

active ingredient: ramipril;

1 tablet contains ramipril 2.5 mg or 5 mg or 10 mg

Excipients: sodium bicarbonate, lactose, sodium croscarmellose, corn starch, sodium stearyl fumarate, iron oxide red (E172) (for tablets 5 mg), iron oxide yellow (E172) (for tablets 2.5 mg and 5 mg).

Method of application and dose.

Preparation for oral administration.

Hartil® is recommended to be taken daily at the same time. The preparation can be taken before, during and after meals, since food intake does not affect the bioavailability of the preparation. Hartil® tablets should be swallowed whole with water. They must not be chewed or crushed. To ensure proper administration, tablets can be divided into equal doses along the dividing line.

Children.

The preparation Hartil® is not recommended for use in children (under the age of 18 years), since data on the safety and efficacy of this preparation for such patients is not enough.

0 reviews

There are no reviews for this product.